0
Sponsored Link

FILE - In this June 22, 2015, photo, a tablet of flibanserin sits on a brochure for Sprout Pharmaceuticals in the company's Raleigh, N.C., headquarters. The Food and Drug Administration on Tuesday, Aug. 18, 2015, approved the first prescription drug designed to boost sexual desire in women, a milestone long sought by a pharmaceutical industry eager to replicate the blockbuster success of impotence drugs for men. (AP Photo/Allen G. Breed)
FILE – In this June 22, 2015, photo, a tablet of flibanserin sits on a brochure for Sprout Pharmaceuticals in the company’s Raleigh, N.C., headquarters. The Food and Drug Administration on Tuesday, Aug. 18, 2015, approved the first prescription drug designed to boost sexual desire in women, a milestone long sought by a pharmaceutical industry eager to replicate the blockbuster success of impotence drugs for men. (AP Photo/Allen G. Breed)

The search for a pill to treat women’s s£xual difficulties have lead to producing what will make women yarn for s£x like harlots after intake. It was pursued and later abandoned by Pfizer, Bayer and Procter & Gamble, among others. But drugs that act on blood flow, hormones and other biological functions all proved ineffective.
The name of the new drug now approved in the USA is called Addyi, known generically as flibanserin. it is the first drug that acts on brain chemicals that affect mood and s£x appetite.

It will help women to become s£xu@lly ar0us£d after intakes.

Women and their doctors will have to decide whether the drug’s modest benefits warrant taking a psychiatric pill on a daily basis.
Stayed tuned with us. We will update on how to get it.




Follow OMOPedia on Twitter!

Like OMOPEDIA on Facebook!


Post a Comment Blogger

 
Top